<tbody id="rk9bv"><noscript id="rk9bv"></noscript></tbody>

<nav id="rk9bv"></nav>
<tbody id="rk9bv"><center id="rk9bv"></center></tbody>
    <rp id="rk9bv"></rp>

  1. <label id="rk9bv"><acronym id="rk9bv"><input id="rk9bv"></input></acronym></label>

      <dd id="rk9bv"><pre id="rk9bv"></pre></dd>

      <progress id="rk9bv"></progress>
      Accurate·Convenient·Reliable


      All for health, health for all
      All for health, health for all
      GeneoDx
      Global world's leading technology industrialization transformation platform of IVD field

      Shanghai GeneoDx Biotech Co., Ltd. (GeneoDx) is a subsidiary of China National Biotec Group Company Limited (CNBG), China National Pharmaceutical Group Co., Ltd. (Sinopharm). GeneoDx is a professional R&D, production, and sales company of domestic and foreign medical devices and in vitro diagnostic reagents.


      Medical diagnosis is one of the key sectors in the development of CNBG's planning. GeneoDx undertakes this part in CNBG. It is also the first company leading CNBG's mixed ownership reform, aiming to promote the rapid development of diagnostic business with institutional innovation. As a unified operation platform company of CNBG's diagnosis sector, GeneoDx integrates functions of R&D, production and trade. By means of independent research and development, technology import, investment, merger and acquisition, it has built a large industrial chain of CNBG's diagnosis sector, and strives to become a leader in the domestic subdivision field. In 2019, GeneoDx completed the first acquisition project of a foreign company within Sinopharm Group, launched the construction of an overseas R&D center, therefore, further accelerated the introduction of global leading technology and broadened the layout overseas.

      Fighting the epidemic

      Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR)

      First batch to get registration certificate



      2020.1

      Novel Coronavirus 2019-nCoV Rapid Detection Kit (LAMP)

      Export whitelist of epidemic prevention materials, CE certification



      2020.6

      Novel Coronavirus(SARS-CoV-2)Neutralizing Antibody Detection Kit (ELISA)

      Export whitelist of epidemic prevention materials, CE certification


      2021.03

      "Great Wall" gas film laboratory, shelter laboratory

      Rapid completion, to help improve nucleic acid capacity




      2022.03
      Products
      Care for life
      All
      • All
      • Reagents
      • Instruments
      • Testing Services
      • Solutions
      All
      • All
      • Reagents
      • Instruments
      • Testing Services
      • Solutions
      Third-Party Medical Testing Services
      Read More

      Shanghai GeneoDx Medical Laboratory Co., Ltd. (GeneoDx Medical) was established in March 2022. It is a wholly-owned subsidiary of GeneoDx, and one of the key tasks of China National Biotech Group's planning and development.
      GeneoDx Medical is beset with a professional examination team, advanced technology and top-notch equipments and facilities, including Sanger platform, multiplex PCR platform, digital PCR platform, immune platform and information analysis platform.  .
      GeneoDx Medical features the detection of tumors and pathogenic microorganisms. By optimizing the allocation of health resources such as medical testing technology, equipment and personnel, it can help in the achievement of graded diagnosis and treatment, alleviation of the workload of medical institutions, decline of medical costs, and complement of diverse medical resources, so as to provide high-quality services to patients. The testing services provided are in the fields of sexually transmitted diseases, prenatal and postnatal care, respiratory pathogens, microbial drug resistance, fungi, oncology, etc.

      Through cooperation with medical institutions and scientific research institutions, GeneoDx Medical deeply explores academic research related to diseases diagnosis/control and treatments, jointly applies for national, provincial, municipal and regional projects of Natural Science Foundation, and tracks and develops new technologies, new products and new services. For the continuous improvement of diagnostic technology and academic status of medical institutions at all levels in the region, it will relentlessly pursue its efforts to meet the needs of hospitals and scientific research institutes.

      Since its establishment, GeneoDx Medical has established a quality management system in strict accordance with the requirements of ISO15189 and CAP to ensure the accuracy and stability of test results, promote mutual recognition of reports, regionalization of coverage and integration of basic data of laboratory management information collection to meet the needs of medical research, health administration and public health management.

      GeneoDx Medical adheres to the corporate philosophy of "All for health, health for all", with independent R&D results and imported technology, is committed to the realization of "guarding life and health with scientific and technological power".

      News
      What's new
      99国产成人免费视频观看